MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
ATGE stock logo

ATGE

Adtalem Global Education Inc.

$106.64
1.57
 (1.49%)
Exchange:  NYSE
Market Cap:  3.874B
Shares Outstanding:  9.185M
Delayed data
Calculate ATGE Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Consumer Defensive
Industry:  Education & Training Services
   
CEO:  Stephen W. Beard
Full Time Employees:  4624
Address: 
500 West Monroe Street
Chicago
IL
60661
US
Website:  https://www.adtalem.com
Adtalem Global Education Inc. is a global enterprise dedicated to delivering comprehensive workforce and educational solutions. Established in 1987 and headquartered in Chicago, Illinois, the company was formerly known as DeVry Education Group Inc. until its name change in May 2017. The organization operates through three distinct segments: 1. Chamberlain: This division offers both academic degree programs and specialized non-degree coursework within the nursing and health professions postsecondary education sector, primarily facilitated by Chamberlain University. 2. Walden: Focused on online learning, the Walden segment provides a wide array of qualifications, from certificates and bachelor’s degrees to master’s and doctoral programs. These offerings, delivered via Walden University, span numerous fields including nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. 3. Medical and Veterinary: This segment is committed to postsecondary education in medical and veterinary sciences, furnishing students with both degree and non-degree program options. Its institutions include the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/01/30 — 2 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue1,450,8261,584,6521,788,290
Gross Profit802,340886,1041,016,860
EBITDA328,946346,959397,670
Operating Income168,170217,054341,542
Net Income93,358136,777237,065

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets2,810,5412,741,4172,752,352
Total Liabilities1,353,2051,372,2821,318,727
Total Stockholders Equity1,457,3361,369,1351,433,625
Total Debt896,191847,853774,000
Cash and Cash Equivalents272,194219,306199,601

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow202,908295,775333,734
Capital Expenditure-37,008-48,893-50,327
Free Cash Flow165,900246,882283,407
Net Income101,752137,713237,065
Net Change in Cash-72,862-53,873-20,038

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)2,187,913Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)2,219,249Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)2,203,581Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)475,439.160Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)482,248.553Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)478,843.857Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)403,820.333Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)406,455.795Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)405,138.064Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)829,337.398Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)841,215.437Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)835,276.418Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)10.580Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)10.600Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)10.530Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)1Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
1.585B  ?P/S
 (TTM)
: 
2.26
?Net Income
 (TTM)
: 
136.777M  ?P/E
 (TTM)
: 
18.55
?Enterprise Value
 (TTM)
: 
4.897B  ?EV/FCF
 (TTM)
: 
14.56
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.17  ?ROIC
 (TTM)
: 
0.13
?Net Debt
 (TTM)
: 
656.389M  ?Debt/Equity
 (TTM)
: 
0.54
?P/B
 (TTM)
: 
3.18  ?Current Ratio
 (TTM)
: 
0.7

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
14.09Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates ATGE intrinsic value between $90.13 – $140.55 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about ATGE valuation

Is Adtalem Global Education Inc. (ATGE) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Adtalem Global Education Inc. (ATGE) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is ATGE a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ATGE trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is ATGE’s P/E ratio?

You can see ATGE’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for ATGE?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is ATGE a good long-term investment?

Whether ATGE fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

ATGE

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

1.49
MARKETSnap

Trading Metrics:

Open: —   Previous Close: —
Day Low: —   Day High: —
Year Low:    Year High: 
Price Avg 50:    Price Avg 200: 
Volume:    Average Volume: 

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Ross University School of Medicine Welcomes New Dean
ATGE or LOPE: Which Is the Better Value Stock Right Now?
ATGE vs. LOPE: Which Stock Is the Better Value Option?
Horizon Investment Services LLC Has $1.67 Million Stock Position in Adtalem Global Education Inc. $ATGE
This Education Stock Posted 34% EPS Growth, So Why Did One Fund Exit a $10.7 Million Stake?
3 Reasons Growth Investors Will Love Adtalem (ATGE)

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read